199 related articles for article (PubMed ID: 32773501)
1. Giardiasis treatment: an update with a focus on refractory disease.
Mørch K; Hanevik K
Curr Opin Infect Dis; 2020 Oct; 33(5):355-364. PubMed ID: 32773501
[TBL] [Abstract][Full Text] [Related]
2. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
Carter ER; Nabarro LE; Hedley L; Chiodini PL
Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
[TBL] [Abstract][Full Text] [Related]
3. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.
Bourque DL; Neumayr A; Libman M; Chen LH
J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34350966
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
Nabarro LE; Lever RA; Armstrong M; Chiodini PL
Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
[TBL] [Abstract][Full Text] [Related]
6. Quinacrine Treatment of Nitroimidazole-Refractory Giardiasis.
Ydsten KA; Hellgren U; Asgeirsson H
J Infect Dis; 2022 May; 225(10):1773-1776. PubMed ID: 34036328
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study.
Neumayr A; Schunk M; Theunissen C; Van Esbroeck M; Mechain M; Hatz C; Mørch K; Soriano Pérez MJ; Sydow V; Sothmann P; Kuenzli E; Rothe C; Bottieau E
Clin Infect Dis; 2021 Oct; 73(8):1517-1523. PubMed ID: 34115100
[TBL] [Abstract][Full Text] [Related]
8. The Use of Quinacrine in Nitroimidazole-resistant Giardia Duodenalis: An Old Drug for an Emerging Problem.
Requena-Méndez A; Goñi P; Rubio E; Pou D; Fumadó V; Lóbez S; Aldasoro E; Cabezos J; Valls ME; Treviño B; Martínez Montseny AF; Clavel A; Gascon J; Muñoz J
J Infect Dis; 2017 Mar; 215(6):946-953. PubMed ID: 28453841
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with refractory giardiasis.
Nash TE; Ohl CA; Thomas E; Subramanian G; Keiser P; Moore TA
Clin Infect Dis; 2001 Jul; 33(1):22-8. PubMed ID: 11389490
[TBL] [Abstract][Full Text] [Related]
10. Giardiasis: report of a case refractory to treatment.
Iza JA; Iza SN; Olivera MJ
Infez Med; 2019 Sep; 27(3):336-339. PubMed ID: 31545780
[TBL] [Abstract][Full Text] [Related]
11. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway.
Mørch K; Hanevik K; Robertson LJ; Strand EA; Langeland N
J Infect; 2008 Apr; 56(4):268-73. PubMed ID: 18328567
[TBL] [Abstract][Full Text] [Related]
12. Treatment of giardiasis.
Gardner TB; Hill DR
Clin Microbiol Rev; 2001 Jan; 14(1):114-28. PubMed ID: 11148005
[TBL] [Abstract][Full Text] [Related]
13. Treatment of giardiasis after nonresponse to nitroimidazole.
Meltzer E; Lachish T; Schwartz E
Emerg Infect Dis; 2014 Oct; 20(10):1742-4. PubMed ID: 25271363
[TBL] [Abstract][Full Text] [Related]
14. Giardiasis in the post genomic era: treatment, drug resistance and novel therapeutic perspectives.
Lalle M
Infect Disord Drug Targets; 2010 Aug; 10(4):283-94. PubMed ID: 20429863
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled, open-label trial of a single day of mebendazole versus a single dose of tinidazole in the treatment of giardiasis in children.
Cañete R; Escobedo AA; González ME; Almirall P; Cantelar N
Curr Med Res Opin; 2006 Nov; 22(11):2131-6. PubMed ID: 17076973
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis.
Escobedo AA; Cañete R; Gonzalez ME; Pareja A; Cimerman S; Almirall P
Ann Trop Med Parasitol; 2003 Jul; 97(5):499-504. PubMed ID: 12930613
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy in the management of giardiasis: What laboratory and clinical studies tell us, so far.
Escobedo AA; Lalle M; Hrastnik NI; Rodríguez-Morales AJ; Castro-Sánchez E; Cimerman S; Almirall P; Jones J
Acta Trop; 2016 Oct; 162():196-205. PubMed ID: 27349189
[TBL] [Abstract][Full Text] [Related]
18. Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.
Yereli K; Balcioğlu IC; Ertan P; Limoncu E; Onağ A
Clin Microbiol Infect; 2004 Jun; 10(6):527-9. PubMed ID: 15191380
[TBL] [Abstract][Full Text] [Related]
19. [Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis].
Cacopardo B; Patamia I; Bonaccorso V; Di Paola O; Bonforte S; Brancati G
Clin Ter; 1995 Dec; 146(12):761-7. PubMed ID: 8681495
[TBL] [Abstract][Full Text] [Related]
20. Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran.
Alizadeh A; Ranjbar M; Kashani KM; Taheri MM; Bodaghi M
East Mediterr Health J; 2006 Sep; 12(5):548-54. PubMed ID: 17333792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
